Immunovant, Inc. SEC filings IMVT
Immunovant, Inc. has 648 filings in SEC EDGAR's recent list, going back to Jan 23, 2019. Its latest annual report, Form ARS, was filed on Jul 22, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (shareholder vote results). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Sep 3, 2026 | Sep 2, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| ARS | Annual report to shareholders | Jul 22, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Jul 22, 2026 | — |
| DEF 14A | Proxy statement | Jul 22, 2026 | Sep 2, 2026 |
| 10-K | Annual report | May 20, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | Feb 6, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Other events
|
Dec 12, 2025 | Dec 10, 2025 |
| 424B5 | Prospectus supplement | Dec 12, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 11, 2025 | Dec 10, 2025 |
| FWP | Free writing prospectus | Dec 11, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2025 | Nov 21, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Aug 28, 2025 | Aug 27, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2025 | Jul 28, 2025 |
| ARS | Annual report to shareholders | Jul 9, 2025 | Mar 31, 2025 |
| DEFA14A | Additional proxy material | Jul 9, 2025 | — |
| DEF 14A | Proxy statement | Jul 9, 2025 | Aug 27, 2025 |
| 10-K | Annual report | May 29, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 29, 2025 | May 29, 2025 |
| S-8 | Employee stock plan registration | Apr 30, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Apr 21, 2025 | Apr 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 19, 2025 | Mar 19, 2025 |
| 10-Q | Quarterly report | Feb 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Other events
|
Jan 24, 2025 | Jan 24, 2025 |
| 424B3 | Prospectus | Jan 24, 2025 | — |
| D | Filing | Jan 21, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 13, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| ARS | Annual report to shareholders | Jun 28, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | Jun 26, 2024 | — |
| DEF 14A | Proxy statement | Jun 26, 2024 | Aug 12, 2024 |
| 10-K | Annual report | May 29, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 29, 2024 | May 29, 2024 |
| S-8 | Employee stock plan registration | Apr 15, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2024 | — |
| CORRESP | Letter to the SEC | Feb 13, 2024 | — |
| 10-Q | Quarterly report | Feb 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2024 | Feb 12, 2024 |
| UPLOAD | Letter from the SEC | Jan 17, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 28, 2023 | Nov 28, 2023 |
| S-3ASR | Automatic shelf registration | Nov 9, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 424B5 | Prospectus supplement | Sep 29, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 28, 2023 | Sep 26, 2023 |
| FWP | Free writing prospectus | Sep 28, 2023 | — |
| FWP | Free writing prospectus | Sep 27, 2023 | — |
| 424B5 | Prospectus supplement | Sep 26, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Aug 23, 2023 | Aug 21, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| DEFA14A | Additional proxy material | Jun 26, 2023 | — |
| DEF 14A | Proxy statement | Jun 26, 2023 | Aug 21, 2023 |
| 10-K | Annual report | May 22, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 22, 2023 | May 22, 2023 |
| S-8 | Employee stock plan registration | Apr 5, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 27, 2023 | Mar 27, 2023 |
| S-8 | Employee stock plan registration | Feb 3, 2023 | — |
| 10-Q | Quarterly report | Feb 3, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2022 | Dec 8, 2022 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2022 | Nov 4, 2022 |
| 424B5 | Prospectus supplement | Oct 5, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 4, 2022 | Oct 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 28, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 7, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Aug 19, 2022 | Aug 17, 2022 |
| 10-Q | Quarterly report | Aug 5, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2022 | Aug 5, 2022 |
| DEFA14A | Additional proxy material | Jun 30, 2022 | — |
| DEF 14A | Proxy statement | Jun 30, 2022 | Mar 31, 2022 |
| S-8 | Employee stock plan registration | Jun 8, 2022 | — |
| 10-K | Annual report | Jun 8, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 8, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2022 | Mar 30, 2022 |
| 10-Q | Quarterly report | Feb 4, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2022 | Feb 4, 2022 |
| S-8 | Employee stock plan registration | Jan 10, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 30, 2021 | Dec 30, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 23, 2021 | Nov 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2021 | Nov 12, 2021 |
| 10-Q | Quarterly report | Nov 5, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2021 | Nov 5, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Sep 15, 2021 | Sep 9, 2021 |
| DEF 14A | Proxy statement | Aug 12, 2021 | Sep 9, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| PRE 14A | Preliminary proxy statement | Aug 2, 2021 | Aug 2, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Aug 2, 2021 | Aug 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2021 | Jul 7, 2021 |
| 10-K | Annual report | Jun 1, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 1, 2021 | Jun 1, 2021 |
| UPLOAD | Letter from the SEC | Feb 18, 2021 | — |
| CORRESP | Letter to the SEC | Feb 17, 2021 | — |
| 8-K |
Current report
Results of operations
|
Feb 16, 2021 | Feb 16, 2021 |
| 10-Q | Quarterly report | Feb 16, 2021 | Dec 31, 2020 |
| UPLOAD | Letter from the SEC | Feb 2, 2021 | — |
| 8-K |
Current report
Other events
|
Feb 2, 2021 | Feb 1, 2021 |
| 424B7 | Filing | Jan 15, 2021 | — |
| 424B5 | Prospectus supplement | Jan 15, 2021 | — |
| EFFECT | Filing | Jan 14, 2021 | — |
| CORRESP | Letter to the SEC | Jan 12, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 11, 2021 | — |
| S-3 | Shelf registration | Jan 4, 2021 | — |
| 424B3 | Prospectus | Nov 12, 2020 | — |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Other events
|
Sep 18, 2020 | Sep 18, 2020 |
| 424B4 | Prospectus | Sep 3, 2020 | — |
| POS EX | Filing | Sep 2, 2020 | — |
| EFFECT | Filing | Sep 1, 2020 | — |
| S-1MEF | Filing | Sep 1, 2020 | — |
| CORRESP | Letter to the SEC | Aug 31, 2020 | — |
| CORRESP | Letter to the SEC | Aug 31, 2020 | — |
| S-1 | Registration statement | Aug 31, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 27, 2020 | — |
| 424B3 | Prospectus | Aug 25, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 25, 2020 | Aug 25, 2020 |
| 424B3 | Prospectus | Aug 21, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Aug 21, 2020 | Aug 19, 2020 |
| DRS | Filing | Aug 19, 2020 | — |
| 424B3 | Prospectus | Aug 12, 2020 | — |
| 10-Q | Quarterly report | Aug 12, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| DEFA14A | Additional proxy material | Jul 9, 2020 | — |
| DEF 14A | Proxy statement | Jul 9, 2020 | Aug 19, 2020 |
| S-8 | Employee stock plan registration | Jun 29, 2020 | — |
| 424B3 | Prospectus | Jun 29, 2020 | — |
| 10-K | Annual report | Jun 29, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
Jun 29, 2020 | Jun 29, 2020 |
| 25-NSE | Delisting notice | Jun 15, 2020 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
May 14, 2020 | May 12, 2020 |
| EFFECT | Filing | Apr 14, 2020 | — |
| 424B4 | Prospectus | Apr 14, 2020 | — |
| POS EX | Filing | Apr 14, 2020 | — |
| S-1MEF | Filing | Apr 14, 2020 | — |
| CORRESP | Letter to the SEC | Apr 10, 2020 | — |
| CORRESP | Letter to the SEC | Apr 10, 2020 | — |
| S-1 | Registration statement | Apr 10, 2020 | — |
| 424B3 | Prospectus | Apr 10, 2020 | — |
| EFFECT | Filing | Apr 9, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2020 | — |
| CORRESP | Letter to the SEC | Apr 8, 2020 | — |
| S-1/A | Amended registration statement | Apr 8, 2020 | — |
| S-1/A | Amended registration statement | Apr 3, 2020 | — |
| DRS | Filing | Apr 1, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 30, 2020 | Mar 30, 2020 |
| CORRESP | Letter to the SEC | Feb 28, 2020 | — |
| S-1/A | Amended registration statement | Feb 28, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 28, 2020 | — |
| S-8 | Employee stock plan registration | Feb 26, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2020 | Feb 18, 2020 |
| 10-Q | Quarterly report | Feb 14, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2020 | Feb 14, 2020 |
| SEC STAFF LETTER | Filing | Feb 6, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2020 | — |
| S-1 | Registration statement | Jan 17, 2020 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change
|
Dec 20, 2019 | Dec 18, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Dec 17, 2019 | Dec 16, 2019 |
| DEFA14A | Additional proxy material | Dec 13, 2019 | — |
| DEFA14A | Additional proxy material | Dec 2, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 2, 2019 | Dec 2, 2019 |
| DEFR14A | Revised definitive proxy statement | Nov 29, 2019 | — |
| DEFM14A | Filing | Nov 27, 2019 | — |
| DEFA14A | Additional proxy material | Nov 25, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2019 | Nov 25, 2019 |
| PRER14A | Proxy statement | Nov 25, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2019 | — |
| DEFA14A | Additional proxy material | Nov 14, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2019 | Nov 13, 2019 |
| 10-Q | Quarterly report | Nov 13, 2019 | Sep 30, 2019 |
| DEFA14A | Additional proxy material | Nov 12, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2019 | Nov 8, 2019 |
| PRER14A | Prelminary proxy statement | Nov 6, 2019 | — |
| CORRESP | Letter to the SEC | Nov 5, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2019 | — |
| DEFA14A | Additional proxy material | Oct 29, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMVT (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1764013
- Former names
- Health Sciences Acquisitions Corp (until Dec 20, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.